Centogene N.V. (CNTG)
0.33
0.01 (1.54%)
At close: Jan 16, 2025, 9:00 PM
Centogene Income Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Revenue | 48.54M | 47.47M | 189.92M | 128.38M | 48.78M | 40.48M | 31.69M | 27.67M |
Cost of Revenue | 31.29M | 27.71M | 161.76M | 86.38M | 26M | 19.94M | 14.94M | 12.86M |
Gross Profit | 17.25M | 19.76M | 28.16M | 42M | 22.77M | 20.54M | 16.75M | 14.81M |
Operating Income | -29.66M | -36.52M | -44.82M | -15.96M | -19.34M | -10.61M | -4.46M | -4.94M |
Interest Income | 204.72K | 3K | 3K | 6K | 16K | 33K | 14K | 26K |
Pretax Income | -35.24M | -38.6M | -46.88M | -21.1M | -20.7M | -11.65M | -5.46M | -5.77M |
Net Income | -35.53M | -38.7M | -46.85M | -21.38M | -20.86M | -11.34M | -5.48M | -5.36M |
Selling & General & Admin | 41.74M | 39.13M | 54.65M | 45.24M | 32.41M | 26.08M | 15.39M | 14.25M |
Research & Development | 12.36M | 17.49M | 19.3M | 14.94M | 9.59M | 6.3M | 6.4M | 5.88M |
Other Expenses | -7.19M | -340K | -970K | -2.22M | 109K | -2.14M | n/a | 290.51K |
Operating Expenses | 46.91M | 56.28M | 72.98M | 57.96M | 42.11M | 30.25M | 21.28M | 19.21M |
Interest Expense | 8.2M | 3.57M | 851K | 1.04M | 2.03M | 1.07M | 1.02M | 829K |
Selling & Marketing Expenses | 12.56M | 9.92M | 9.86M | 7.58M | 9.25M | 7.47M | 5.9M | 5.36M |
Cost & Expenses | 78.19M | 83.99M | 234.74M | 144.34M | 68.12M | 50.19M | 36.22M | 32.07M |
Income Tax | 287K | 107K | -24K | 281K | 158K | -310K | 14K | -408K |
Shares Outstanding (Basic) | 28.16M | 26.81M | 22.44M | 20.91M | 16.41M | 19.86M | 19.86M | 19.86M |
Shares Outstanding (Diluted) | 28.16M | 26.81M | 22.44M | 20.91M | 16.41M | 19.86M | 19.86M | 19.86M |
EPS (Basic) | -1.26 | -1.44 | -2.09 | -1.02 | -1.27 | -0.57 | -0.28 | -0.27 |
EPS (Diluted) | -1.26 | -1.44 | -2.09 | -1.02 | -1.27 | -0.57 | -0.28 | -0.27 |
EBITDA | -19.43M | -26M | -41.03M | -50.12M | -12.74M | -5.4M | -1.29M | -2.94M |
Depreciation & Amortization | 7.61M | 10.19M | 20.77M | 14.09M | 6.56M | 5.34M | 3.04M | 2.19M |